Quick Answer
Regenerative Medical Technology Group Inc. reported Net Income of -$5.56 million for fiscal year 2024.
Regenerative Medical Technology Group Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2024 | -$5.56M | +43.3% |
| 2023 | -$9.81M | -78.2% |
| 2022 | -$5.51M | +57.3% |
| 2021 | -$12.88M | -118.5% |
| 2020 | -$5.90M | -135.0% |
| 2019 | -$2.51M | -21.9% |
| 2018 | -$2.06M | -445.8% |
| 2017 | -$377.0K | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$4.35M | -390.8% | -233.4% |
| June 30, 2025 | -$1.31M | +37.1% | -71.8% |
| March 31, 2025 | -$760.0K | +61.2% | +14.3% |
| September 30, 2024 | -$887.1K | +84.9% | +57.3% |
| June 30, 2024 | -$2.08M | -2.3% | -5.9% |
| March 31, 2024 | -$1.96M | -17.4% | +66.5% |
| September 30, 2023 | -$5.86M | -335.7% | -188.5% |
| June 30, 2023 | -$2.03M | -36.0% | -21.6% |
- Regenerative Medical Technology Group Inc. showed an increase of +43.3% in Net Income compared to the prior fiscal year.
- Over the 2017–2024 period, Regenerative Medical Technology Group Inc.’s net income has declined by 1375.6% (from -$377.0 thousand to -$5.56 million).
- The most recent figure is from Regenerative Medical Technology Group Inc.’s fiscal year 2024 report (Form 10-K), filed with the SEC on April 15, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: